Yves Pastore
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Optimizing Hydroxyurea Dosage With Pharmakokinetic in Patients Suffering of Moderate to Severe Sickle Cell Anemia (NCT06761560) | Yves Pastore | 2026-02-03 |
Track Yves Pastore automatically
Every clearance here is in the API, with alerts when new ones post.